© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Context Therapeutics Inc. (CNTX) shows an Average True Range (ATR) of 0.1 and an Enterprise Value of 6.31M. Its average trading volume over the past 3 months is 444.24K, indicating liquidity. These fundamental metrics provide insight into CNTX's underlying financial health and market activity.
Context Therapeutics Inc. (CNTX) technical indicators as of December 22, 2025: the SMA 20 is 15.82%, SMA 50 at 9.01%, and SMA 200 at 44.81%. The RSI 14 value is 64.95, suggesting its current momentum. These technical analysis signals help assess CNTX's price trends and potential future movements.
Context Therapeutics Inc. (CNTX) stock performance overview as of December 22, 2025: The 52-week high is $1.55 (currently -18.06% below), and the 52-week low is $0.49 (currently 159.18% above). Over the past year, CNTX's performance is -8.63%, compared to the S&P 500's 12.87% change.
According to market data, Context Therapeutics Inc. (CNTX) stock's recent performance metrics show that over the last month, CNTX is 17.59%, with a Year-to-Date (YTD) performance of 20.95%. Over the past year, the stock has seen a -8.63% change. These figures summarize CNTX's price movements across various periods, reflecting its historical returns.
According to current financial data, CNTX stock's P/E (TTM) ratio is -3.53, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CNTX, including P/S (N/A), P/B (1.46), and P/FCF (-5.39), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.